Osteoporosis is a systemic metabolic bone disease with characteristics of bone loss and
microstructural degeneration. The personal and societal costs of osteoporosis are …

Skeletal disorders are among the leading debilitating factors affecting millions of people
worldwide. The use of stem cells for tissue repair has raised many promises in various …

Osteoporosis is one of the most common skeletal disorders caused by the imbalance
between bone formation and resorption, resulting in quantitative loss of bone tissue. Since …

Osteoporosis is a progressive skeletal disease characterized by decreased bone mass and
degraded bone microstructure, which leads to increased bone fragility and risks of bone …

The regeneration capacity of the osteoporotic bones is generally lower than that of the
normal bones. Current methods of bone defect treatment for osteoporosis are not always …

Mesenchymal stem/stromal cells (MSCs) can regenerate tissues by direct differentiation or
indirectly by stimulating angiogenesis, limiting inflammation, and recruiting tissue-specific …

Extrusion-based bioprinting (EBB) is a rapidly developing technique that has made
substantial progress in the fabrication of constructs for cartilage tissue engineering (CTE) …

Osteoporosis is a systemic metabolic bone disorder characterized by a decrease in bone
mass and degradation of the bone microstructure, leaving bones that are fragile and prone …

Osteoporosis (OP) is one of the most common diseases in the elderly, and it is not effectively
solved by current treatments. Mesenchymal stem cells (MSCs) have multiple differentiation …

Purpose: Osteoporosis is more likely to cause serious complications after joint replacement,
mainly due to physiological defects of endogenous osteogenic cells and the pathological …